Physician profile
Ross E Krasnow
NPI 1437471992
$1,695.39
in general payments reported to CMS, 2019-2025
22 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $54.44 · 2021: $15.94 · 2022: $94.95 · 2023: $188 · 2024: $641 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Travel and Lodging: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.59 |
| Travel and Lodging | $222.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $387.80 | 2019-2024 | Aquabeam System |
| Agiliti Surgical, INC. | $231.98 | 2024 | Sonablate Hifu |
| Photocure INC | $155.37 | 2019-2022 | |
| Janssen Biotech, INC. | $124.47 | 2024 | Erleada |
| Ferring Pharmaceuticals INC. | $117.88 | 2025 | Adstiladrin |
| Immunitybio, INC. | $101.89 | 2025 | |
| Genentech, INC. | $95.33 | 2019 | |
| Boston Scientific Corporation | $72.87 | 2024-2025 | Rezum Generator, Ams 700 |
| Merck Sharp & Dohme LLC | $52.37 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Olympus America INC. | $48.21 | 2023 | Itind System |
| Intuitive Surgical, INC. | $36.27 | 2020 | |
| Progenics Pharmaceuticals, INC. | $35.65 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $33.07 | 2023 | Orgovyx |
| Ethicon US, LLC | $32.33 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $32.08 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $24.41 | 2023 | |
| Coloplast Corp | $23.23 | 2024 | |
| Pfizer INC. | $22.10 | 2023 | |
| Teleflex LLC | $19.59 | 2019 | |
| Davol INC. | $18.17 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.94 | 2021 | |
| Cook Medical LLC | $14.38 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Krasnow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.